Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Cell

• Publication date

  2016-03-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccell.2016.01.013PMID 26908355
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oncogenic roles of EMT-inducing transcription factors

  2014cited by this paper
• Systematic integration of RNA-Seq statistical algorithms for accurate detection of differential gene expression patterns

  2014cited by this paper
• voom: precision weights unlock linear model analysis tools for RNA-seq read counts

  2014cited by this paper
• ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases

  2014cited by this paper
• SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer

  2014influential reference
• Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis

  2014cited by this paper
• Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles

  2014cited by this paper
• Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR-SET7-deficient livers

  2014cited by this paper
• Hitting the 'mark': interpreting lysine methylation in the context of active transcription.

  2014cited by this paper
• Context-specific regulation of cancer epigenomes by histone and transcription factor methylation

  2014cited by this paper
• Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

  2014cited by this paper
• The methyltransferase SMYD3 mediates the recruitment of transcriptional cofactors at the myostatin and c-Met genes and regulates skeletal muscle atrophy.

  2013cited by this paper
• TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

  2013cited by this paper
• Software for Computing and Annotating Genomic Ranges

  2013cited by this paper
• Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.

  2012cited by this paper
• SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.

  2012cited by this paper
• Targeting epigenetic readers in cancer.

  2012cited by this paper
• c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

  2012cited by this paper
• Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.

  2012cited by this paper
• ggbio: an R package for extending the grammar of graphics for genomic data

  2012cited by this paper
• Transcriptional amplification in tumor cells with elevated c-Myc.

  2012cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation

  2012cited by this paper
• Operating on chromatin, a colorful language where context matters.

  2011cited by this paper
• The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma

  2011cited by this paper
• Integrated genome-wide analysis of transcription factor occupancy, RNA polymerase II binding and steady-state RNA levels identify differentially regulated functional gene classes

  2011cited by this paper
• Cutadapt removes adapter sequences from high-throughput sequencing reads

  2011cited by this paper
• An integrated ChIP-seq analysis platform with customizable workflows

  2011cited by this paper
• Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3

  2011cited by this paper
• Aberrations of EZH2 in Cancer

  2011cited by this paper
• Structural and biochemical studies of human lysine methyltransferase Smyd3 reveal the important functional roles of its post-SET and TPR domains and the regulation of its activity by DNA binding

  2011cited by this paper
• Lysine methylation regulates E2F1-induced cell death.

  2010cited by this paper
• Epithelial-mesenchymal transitions and hepatocarcinogenesis.

  2010cited by this paper
• Differential expression analysis for sequence count data

  2010cited by this paper
• Nucleosome-interacting proteins regulated by DNA and histone methylation.

  2010cited by this paper
• ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions.

  2009cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• Requirement of Histone Methyltransferase SMYD3 for Estrogen Receptor-mediated Transcription*

  2009cited by this paper
• Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.

  2009cited by this paper
• Gene ARMADA: an integrated multi-analysis platform for microarray data implemented in MATLAB

  2009cited by this paper
• Hepatocyte Nuclear Factor 4α Coordinates a Transcription Factor Network Regulating Hepatic Fatty Acid Metabolism

  2009cited by this paper
• Dominant and redundant functions of TFIID involved in the regulation of hepatic genes.

  2008cited by this paper
• Model-based Analysis of ChIP-Seq (MACS)

  2008cited by this paper
• Mapping and quantifying mammalian transcriptomes by RNA-Seq

  2008cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• STAMP: a web tool for exploring DNA-binding motif similarities

  2007cited by this paper
• Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4.

  2007cited by this paper
• Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas

  2007cited by this paper
• Enhanced SMYD3 expression is essential for the growth of breast cancer cells

  2006cited by this paper
• Plasticity and expanding complexity of the hepatic transcription factor network during liver development.

  2006cited by this paper
• IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis.

  2005cited by this paper
• Histone modifications defining active genes persist after transcriptional and mitotic inactivation

  2005cited by this paper
• CAR, the continuously advancing receptor, in drug metabolism and disease.

  2005cited by this paper
• β‐Catenin mutations in a mouse model of inflammation‐related colon carcinogenesis induced by 1,2‐dimethylhydrazine and dextran sodium sulfate

  2005cited by this paper
• SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

  2004influential reference
• Active genes are tri-methylated at K4 of histone H3

  2002cited by this paper
• BIOINFORMATICS APPLICATIONS NOTE

  2001cited by this paper
• N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation.

  1996cited by this paper
• An Introduction to the Bootstrap

  1995cited by this paper
• Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice.

  1990cited by this paper
• On Information and Sufficiency

  1951cited by this paper
• Chromatin Modifications and Their Function

  year unknowncited by this paper

• SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3

  2026cites this paper
• Co-option of ILF2/3 in primates restrains Alu hyper-editing to enable cell fate transitions

  2026cites this paper
• A novel molecule ZYZ329 targeting histone methyltransferase SMYD3 suppresses pathological angiogenesis via the driven mitochondrial ROS/HIF-1α/VEGFA axis.

  2026cites this paper
• Bifaceted functions of histone methyltransferases.

  2025cites this paper
• Metabolomic and Computational Studies for Antiproliferative Potential of Corchorus olitorius Methanol Root Extract and Its Nanocrystals

  2025cites this paper
• Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis

  2025cites this paper
• SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47

  2025cites this paper
• Arsenic disrupts H3K9me3 and H3K27me3 balance by biasing PRC2.1 and PRC2.2 activity via PALI1 inhibition in carcinogenesis

  2025cites this paper
• The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis

  2025influential citation
• Cytotoxic Potential and Metabolomic Profiling of Solanum lycopersicum Roots Extract and Their Nanocrystals: An In Silico Approach

  2025cites this paper
• SMYD3 as an Epigenetic Regulator of Renal Tubular Cell Survival and Regeneration Following Acute Kidney Injury in Mice

  2025cites this paper
• SMYD3 Activates Fatty Acid β-oxidation to Promote Self-Renewal of Leukemia Stem Cells.

  2025cites this paper
• The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics

  2025cites this paper
• SMYD3 drives cell cycle and epithelial-mesenchymal transition pathways through dual gene transcriptional repression and activation in HPV-negative head and neck cancer

  2025cites this paper
• Integrated computational and biosensor-based strategies for the discovery of allosteric SMYD3 ligands using diperodon as a starting point.

  2025cites this paper
• Molecular pathology of microRNA-103a as a probable diagnostic and therapeutic tumor marker

  2025cites this paper
• Chemoprevention of hepatocellular carcinoma using N-acetylgalactosamine-conjugated siRNAs

  2025cites this paper
• Methyltransferases in cancer drug resistance: Unlocking the potential of targeting SMYD3 to sensitize cancer cells.

  2024cites this paper
• RNA Damage Responses in Cellular Homeostasis, Genome Stability, and Disease.

  2024cites this paper
• Covalent inhibitors meet epigenetics: New opportunities.

  2024cites this paper
• A novel small molecule ZYZ384 targeting SMYD3 for hepatocellular carcinoma via reducing H3K4 trimethylation of the Rac1 promoter

  2024cites this paper
• Smyd3-mediated immuno-modulation in HPV-negative head and neck squamous cell carcinoma mouse models

  2024cites this paper
• SMYD3 Controls Ciliogenesis by Regulating Distinct Centrosomal Proteins and Intraflagellar Transport Trafficking

  2024cites this paper
• The novel SMYD3 inhibitor EM127 impairs DNA repair response to chemotherapy-induced DNA damage and reverses cancer chemoresistance

  2024cites this paper
• THAP3 recruits SMYD3 to OXPHOS genes and epigenetically promotes mitochondrial respiration in hepatocellular carcinoma

  2024cites this paper
• SMYD3: a new regulator of adipocyte precursor proliferation at the early steps of differentiation

  2023cites this paper
• The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer

  2023cites this paper
• Smyd3 negatively regulates the anti-viral pathway by promoting TAK1 degradation in teleost fish

  2023cites this paper
• The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark

  2023cites this paper
• SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck

  2023cites this paper
• SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner

  2023cites this paper
• SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma

  2023influential citation
• Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription

  2023cites this paper
• Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy

  2023cites this paper
• Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases

  2023cites this paper
• Endonucleosis mediates internalization of cytoplasm into the nucleus

  2023cites this paper
• SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer

  2023cites this paper
• SMYD3 Promotes Cell Cycle Progression by Inducing Cyclin D3 Transcription and Stabilizing the Cyclin D1 Protein in Medulloblastoma

  2022cites this paper
• Identifying novel SMYD3 interactors on the trail of cancer hallmarks

  2022influential citation
• SMYD5 acts as a potential biomarker for hepatocellular carcinoma.

  2022cites this paper
• SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells

  2022cites this paper
• Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis

  2022cites this paper
• Epigenetic silencing by SMYD3 represses tumor intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck

  2022cites this paper
• Journal Pre-proof Methyltransferase SMYD3 impairs hypoxia tolerance by augmenting hypoxia signaling independent of its enzymatic activity

  2022cites this paper
• Methyltransferase SMYD3 impairs hypoxia tolerance by augmenting hypoxia signaling independent of its enzymatic activity

  2022cites this paper
• Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma

  2022cites this paper
• Role of microRNAs in hepatocellular cancer pathogenesis and prognosis

  2022cites this paper
• Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3.

  2022cites this paper
• SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription

  2022influential citation
• Clinicopathological and Prognostic Significance of SMYD3 in Human Cancers: A Systematic Review and Meta-analysis.

  2022cites this paper
• Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease

  2021cites this paper
• Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase

  2021cites this paper
• LncRNA LTSCCAT promotes tongue squamous cell carcinoma metastasis via targeting the miR-103a-2-5p/SMYD3/TWIST1 axis

  2021cites this paper
• Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway

  2021cites this paper
• SMYD3: a regulator of epigenetic and signaling pathways in cancer

  2021influential citation
• SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner

  2021cites this paper
• Overexpression of SMYD3 contributes to sorafenib resistance by epigenetically activating the expression of multiple cancer-promoting genes in hepatocellular carcinoma

  2021influential citation
• Annotations of Recurrent Structural Variant Events in Pan-cancer Whole Genome Data for Precision Medicine

  2021cites this paper
• The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development

  2021cites this paper
• Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth

  2021influential citation
• Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening

  2021cites this paper
• Mechanism of the Conformational Change of the Protein Methyltransferase SMYD3: A Molecular Dynamics Simulation Study

  2021cites this paper
• Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors

  2021cites this paper
• SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters

  2021cites this paper
• Playing on the Dark Side: SMYD3 Acts as a Cancer Genome Keeper in Gastrointestinal Malignancies

  2021cites this paper
• Functions of SMYD proteins in biological processes: What do we know? An updated review.

  2021cites this paper
• Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer

  2021cites this paper
• Role of CYP4F2 as a novel biomarker regulating malignant phenotypes of liver cancer cells via the Nrf2 signaling axis

  2020cites this paper
• Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial–Mesenchymal Transition

  2020cites this paper
• Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg.

  2020cites this paper
• Long Noncoding RNA EZR-AS1 Regulates the Proliferation, Migration, and Apoptosis of Human Venous Endothelial Cells via SMYD3

  2020cites this paper
• The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review

  2020cites this paper
• Roles of Histone Modifications in Gastrointestinal Tumorigenesis

  2020cites this paper
• Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer

  2020cites this paper
• SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer

  2020cites this paper
• Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma

  2020cites this paper
• VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR

  2020cites this paper
• Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase

  2020cites this paper
• SET and MYND domain-containing protein 3 inhibits tumor cell sensitivity to cisplatin

  2020cites this paper
• The impact of cell geometry and the cytoskeleton on the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase suggests that the epigenetic machinery is mechanosensitive

  2020cites this paper
• Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality

  2020cites this paper
• SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways

  2020influential citation
• Identifying modules of cooperating cancer drivers

  2020cites this paper
• Biophysical approaches in a structure-guided SMYD3 ligand discovery

  2019cites this paper
• Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends.

  2019cites this paper
• LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells

  2019cites this paper
• ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma

  2019cites this paper
• Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2

  2019cites this paper
• A Novel lncRNA IHS Promotes Tumor Proliferation and Metastasis in HCC by Regulating the ERK- and AKT/GSK-3β-Signaling Pathways

  2019influential citation
• Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials

  2019cites this paper
• Exploration of the Substrate Preference of Lysine Methyltransferase SMYD3 by Molecular Dynamics Simulations

  2019cites this paper
• Function of the MYND Domain and C-Terminal Region in Regulating the Subcellular Localization and Catalytic Activity of the SMYD Family Lysine Methyltransferase Set5

  2019cites this paper
• Is MYND Domain-Mediated Assembly of SMYD3 Complexes Involved in Calcium Dependent Signaling?

  2019cites this paper
• Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer

  2019cites this paper
• Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer

  2019cites this paper
• Unveiling the biochemistry of the epigenetic regulator SMYD3.

  2019cites this paper
• Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3.

  2019cites this paper
• Bookmarking by Non-pioneer Transcription Factors during Liver Development Establishes Competence for Future Gene Activation

  2019cites this paper
• SMYD3 promotes the epithelial–mesenchymal transition in breast cancer

  2018influential citation
• The Smyd Family of Methyltransferases: Role in Cardiac and Skeletal Muscle Physiology and Pathology.

  2018cites this paper